Vascular Access Device Market: Growth, Size, Share, and Trends

Report Code MD 5434
Published in Feb, 2025, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Vascular Access Devices Market by Type (Central (PICC, Tunneled, Non-Tunnled, Port (Conventional, Power)), Peripheral (Venous (PIVC, Midline), Arterial) Intraosseous Device), Route of Insertion (IV, SC, IO), Application, End User - Global Forecast to 2030

Overview

The global vascular access devices market, valued at US$5.60 billion in 2023, is forecasted to grow at a robust CAGR of 7.1%, reaching US$5.99 billion in 2024 and an impressive US$9.05 billion by 2030. The increasing prevalence of chronic diseases, such as cancer and chronic kidney diseases, drives market growth. Additionally, increased government support for the construction of healthcare infrastructure and technological advancements are expected to impact market growth. The increasing number of hospitals globally also poses an opportunistic factor for market growth.

Vascular Access Devices Market – Global Forecast and Key Opportunities to 2030

Attractive Opportunities in the Vascular Access Devices Market

Asia Pacific

Market growth in the Asia Pacific can be attributed to the rising prevalence of chronic diseases and an increasing number of hospitals. Additionally, an increased presence of vascular access device manufacturers also contributes to the regional market growth.

The growth of the Asia Pacific vascular access devices market can be attributed to the increasing prevalence of chronic diseases such as cancer, chronic kidney diseases, CVDs.

The increasing number of hospitals and technological advancements in the vascular access devices are the factors that are likely to promote significant growth opportunity of the market.

The Asia Pacific is the fastest growing region in the vascular access devices market. The regional market is projected to reach USD 2.87 billion by 2030, at a CAGR of 8.4% during the forecast period.

The Asia Pacific is the second largest regional market for vascular access devices due to the increasing geriatric population and rising government support for various healthcare infrastructures.

Global Vascular Access Devices Market Dynamics

DRIVER: Growing prevalence of lifestyle diseases

The increasing prevalence of lifestyle diseases such as diabetes and obesity, as well as diseases associated with alcohol consumption and smoking, have increased globally owing to unhealthy eating habits and a lack of physical activities. For instance, as per the CDC, 38.4 million people in the US had diabetes in 2021, with 29.7 million diagnosed cases (including 29.4 million adults). Also, on a global scale, diabetes has increased from 200 million in 1990 to 830 million in 2022 (as per the WHO report). Additionally, low- and middle-income countries experience the fastest market growth for vascular access devices due to the huge patient pool, which creates the need for advanced solutions to manage these diseases. The growing prevalence of chronic kidney diseases (CKDs) also fuels the market growth. For instance, as per the CDC, there are around 35.5 million adults estimated to have CKD in the US, which is estimated to be around 14.0% of the US population. The increasing incidence of diabetes and CKD has thereby increased the need for vascular access devices and subsequent long-term therapies for these diseases.

RESTRAINT: Product recalls and failures

The market for vascular access devices is restrained by a rising number of product recalls and failures. There has been an increase in the number of product recalls due to the stringent regulatory rules imposed by various government organizations, such as FDA and CDSCO. Product malfunctioning is one of the prime restraints that can negatively impact the market due to the severe complications faced by patients. Vascular access devices directly come in contact with blood; hence, product malfunctioning can cause serious damage to the patients, including death. For this reason, several products have been recalled from various regions. For instance, in January 2025, Vygon (France) company called their one batch of Lifecath PICC product because that batch was damaged. Again, in August 2023, Teleflex Incorporated (US) recalled their Pressure Injectable Catheter Kits due to mislabelling. Similarly, in May 2022, they recalled their Arrow MAC Two-lumen central venous access kits and Arrowg+ard Blue three-lumen central venous catheter (CVC) kits as there was a risk of cross-lumen leaks. Hence, this number of product recalls and failures might decrease the adoption of the vascular access devices market.

 

OPPORTUNITY: Technological Advancements

Advancements in the vascular access devices market have been due to technological improvements. Ultrasound is a broadly available, non-invasive technique and is thus the most broadly used vessel visualization method. As a cost-effective method, it allows the evaluation of vascular access maturity and diagnosis of complications; in recent years, image-guided vascular access has emerged as a new, efficient method offering precise results. The use of ultrasound imaging during vascular access device insertion has become more common, which helps healthcare professionals visualize the veins in real time, increasing the success rate of first-attempt insertions and reducing complications such as accidental arterial punctures and hematoma formation. Due to the increasing use of vascular access devices, there has been an advancement in image-guided vascular access devices, which has, in turn, helped improve the market share of these devices. In addition, the combination of a needle-tracking system with ultrasound guidance can help reduce attempts and improve accuracy for successful vascular access. This combination has been recognized by the American Institute of Ultrasound in Medicine; this has enhanced safety and ease for both clinicians and patients. Moreover, the development of bone-anchored ports for vascular access during chemotherapy and kidney dialysis has also helped healthcare workers provide better treatment to patients.

CHALLENGES: Shortage of Skilled Professionals

There is a huge demand for skilled professionals, including registered nurses, physicians, doctors, and other trained healthcare professionals, to handle vascular access devices as their improper insertion may cause medical complications in patients, such as damage to blood vessels, bleeding at the site, entrance of air into the vein (air embolus), injury to the lung (pneumothorax), and bloodstream infections. According to a survey on the latest business conditions conducted by the National Association for Business Economics (NABE), 35% of participants reported that there is a shortage of skilled professionals in the US. It is projected that there will be a shortfall of 2,300 oncologists by 2025, as around 22% of them will be retired, and only 13.9% are 40 years or younger (American Society of Clinical Oncology). This shortage of skilled professionals in major markets across the globe is expected to affect the demand and uptake of vascular access devices, as very few professionals are able to perform this on critical patients. In addition, an increasing patient load and a growing demand for complex procedures also demand an increase in skilled professionals for performing vascular access procedures, a shortage of which can lead to reduced market growth.

Global Vascular Access Devices Market Ecosystem Analysis

The vascular access device market ecosystem includes providers, regulatory bodies, and end users. Key market players include medical device companies offering PICC lines, central venous catheters (CVCs), implantable ports, peripheral IV catheters, and other vascular access devices catering to the needs of various patients. Regulatory authorities such as the FDA, European Commission, and CDSCO ensure product safety, while technological advancements (antimicrobial coatings, ultrasound-guided insertions) enhance patient outcomes. Hospitals, specialty clinics, and home care settings are primary end users, with reimbursement policies impacting adoption. Market consolidation, partnerships, and geographic expansions shape competition, with North America leading, while the Asia Pacific sees rapid growth due to healthcare infrastructure advancements. The ecosystem thrives on R&D investments, strategic collaborations, and evolving patient-centric innovations, ensuring sustained market evolution.

Vascular Access Devices Market Ecosytem
 

By type, the central venous access devices segment commanded the largest market share in 2023.

On the basis of type, the vascular access devices market is divided into central venous access devices, peripheral vascular access devices, intraosseous vascular access devices, and accessories. Among these, the central venous access devices hold the largest market share in 2023 due to the increasing prevalence of diseases requiring vascular access diseases, such as cancer, chronic kidney diseases (CKDs), and CVDs. For instance, as per the CDC, in February 2025, there were 1,777,566 new cancer cases reported in the US, and the prevalence of the disease has continuously increased. Additionally, the CDC stated in May 2024 that more than 1 in 7 adults in the US suffer from CKDs, which has increased the need for dialysis among patients. Moreover, as per the National Kidney Foundation, around 10% of the population is affected by CKDs globally, which shows a rising need for long-term intravenous treatment, which, in turn, has also increased the demand for vascular access devices. Consequently, the increasing need for these devices has contributed to the segmental growth in the vascular access devices market.

By end user, hospitals held largest market share in 2023.

On the basis of end users, the vascular access devices market has been classified into hospitals, clinics & ambulatory care centers, and other end users (including nursing homes, laboratories, diagnostic & imaging centers, and home healthcare agencies). The hospitals segment accounted for the largest market share in 2023 due to rising funding programs to build infrastructure in rural and underserved areas and the increasing prevalence of diseases necessitating vascular access devices. Hospitals have been one of the most preferred places to treat diseases due to technological advances and the availability of the best treatment options for different illnesses. Additionally, the insertion of vascular access devices requires skilled healthcare professionals, who are also majorly available in hospitals due to better payments and more career advancements. Hospitals have the ability and resources to deploy advanced technologies and methods to ensure the best possible treatment options for patients suffering from cancer and kidney diseases. Hence, the increasing number of hospitals equipped with advanced medical devices, such as imaging techniques that help the insertion of vascular access devices, globally also drives market growth.

Asia Pacific to show at the highest CAGR during study period

The Asia Pacific is the fastest-growing regional market due to the rapid expansion of vascular access device companies across key countries such as China, Japan, and India. In addition, there are numerous market participants, such as Medi-Tech Devices Pvt. Ltd (India), Nipro (Japan), Terumo Corporation (Japan), Guangdong Baihe Medical Technology Co., Ltd. (China), and Shanghai Puyi Medical Instruments Co., Ltd (China) in these countries, which contribute to market expansion and advancements in the regional market. As these players are continuously investing in R&D and launching new vascular access devices globally, the market is continuously increasing. Additionally, the increasing aging population has increased the demand for vascular access devices. As this population is more prone to having chronic diseases such as CKDs and CVDs, there is an increasing chance of long-term hospitalization, which can require vascular access devices. Moreover, the increasing lifestyle diseases, such as diabetes, obesity, and hypertension, have also contributed to the market growth due to an increasing prevalence of these diseases. For instance, as per WHO, there are around 220 million people in India live with hypertension, and 77 million people above the age of 18 years are suffering from diabetes. These significant factors are contributing to the Asia Pacific’s vascular access device market during the forecast period.

JAPAN ACCOUNTED FOR LARGEST MARKET SHARE IN ASIA PACIFIC IN 2023
ASIA PACIFIC FASTEST GROWING MARKET IN THE REGION
Vascular Access Devices Market Region

Recent Developments of Vascular Access Devices Market

  • Product Approval: In September 2024, B. Braun SE was granted 510(K) clearance by the US FDA for the Introcan Safety 2 Deep Access IV Catheter, the newest addition to the Introcan Safety 2 IV Catheter portfolio.
  • Agreement: In June 2023, Teleflex Incorporated (US) has been awarded two group purchasing agreements with Premier, Inc. The new agreements allow Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for Teleflex’s Central Venous and Arterial Vascular Access products.
  • Product Launch: In June 2022, Teleflex Incorporated (US) launched an Arrow Pressure Injectable Midline Catheter in Australia and New Zealand. The addition of the pressure injectable catheter further enhances the Midline portfolio to meet the expanded needs of clinicians and is designed to improve patient safety.
  • Acquisition: In January 2022, ICU Medical, Inc. (US) acquired Smiths Medical (US) from Smiths Group PLC. The Smiths Medical business includes syringe and ambulatory infusion devices, vascular access, and vital care products.

Key Market Players

Want to explore hidden markets that can drive new revenue in Vascular Access Devices Market?

Scope of the Report

Report Metric Details
Market size available for years 2024-2030
Base Year Considered 2023
Forecast period 2024-2030
Forecast units Value (USD Million/Billion)
Segments covered Type, Route of Insertion, Application, End User, and Region
Geographies covered North America (US & Canada), Europe (Germany, UK, France, Italy, Spain, nordic countries and RoE), Asia Pacific (Japan, China, Australia, South Korea, India, and the RoAPAC), Latin America (Brazil, Mexico, and RoLATAM), Middle East & Africa (GCC Countries, RoMEA)

 

Key Questions Addressed by the Report

Which are the top industry players in the global vascular access devices market?
The top market players in the global vascular access device market include The prominent players in this market are Becton, Dickinson and Company (US), ICU Medical (US), Teleflex Incorporated (US), B. Braun SE (Germany), AngioDynamics, Inc. (US), Terumo Corporation (Japan), and Nipro (Japan)
What are some of the major drivers for this market?
Growth in the vascular access devices market can primarily be attributed to factors such as the growing prevalence of lifestyle diseases, the increasing number of chemotherapy procedures, and the growing use of vascular access devices in pediatric patients.
Which end users have been included in the global vascular access devices market?
This report contains the following end user segments:
  • Hospitals
  • Clinics & Ambulatory Care Centers
  • Other End Users
Which type of vascular access device is lucrative for the vascular access devices market?
The peripheral vascular access devices segment is expected to witness the highest growth rate during the forecast period.
Which region is lucrative for the vascular access device market?
The Asia Pacific market is expected to witness the highest CAGR during the forecast period.

 

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Vascular Access Devices Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table Of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
41
RESEARCH METHODOLOGY
46
EXECUTIVE SUMMARY
60
PREMIUM INSIGHTS
68
MARKET OVERVIEW
72
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Growing prevalence of lifestyle diseases
    - Increasing popularity of chemotherapy procedures among cancer patients
    - Rising use of vascular access devices among pediatric patients
    RESTRAINTS
    - High cost of installation and maintenance of vascular access devices
    - Rising product recalls and failures
    OPPORTUNITIES
    - Technological advancements
    - Increasing number of hospitals and expanding patient pool
    CHALLENGES
    - Shortage of skilled healthcare professionals
    - Risks associated with use of vascular access devices
  • 5.3 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - Imaging and navigation technologies
    - Catheter securement and stabilization technologies
    COMPLEMENTARY TECHNOLOGIES
    - AI and ML
    ADJACENT TECHNOLOGIES
    - Infection control technologies
  • 5.4 INDUSTRY TRENDS
    MINIMALLY INVASIVE VASCULAR ACCESS PROCEDURES
    INNOVATIONS IN CATHETER MATERIALS AND COATINGS
  • 5.5 VALUE CHAIN ANALYSIS
  • 5.6 ECOSYSTEM ANALYSIS
    ROLE IN ECOSYSTEM
  • 5.7 SUPPLY CHAIN ANALYSIS
  • 5.8 TRADE ANALYSIS
    IMPORT DATA FOR HS CODE 901839
    EXPORT DATA FOR HS CODE 901839
  • 5.9 PORTER’S FIVE FORCES ANALYSIS
    THREAT OF NEW ENTRANTS
    THREAT OF SUBSTITUTES
    BARGAINING POWER OF BUYERS
    BARGAINING POWER OF SUPPLIERS
    INTENSITY OF COMPETITIVE RIVALRY
  • 5.10 KEY STAKEHOLDERS & BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    KEY BUYING CRITERIA
  • 5.11 REGULATORY ANALYSIS
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    REGULATORY FRAMEWORK
    - North America
    - Europe
    - Asia Pacific
    - Latin America
    - Middle East & Africa
  • 5.12 PATENT ANALYSIS
    INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
  • 5.13 PRICING ANALYSIS
    INDICATIVE PRICING TREND OF VASCULAR ACCESS DEVICES, BY KEY PLAYER, 2021–2023
    INDICATIVE PRICING TREND OF VASCULAR ACCESS DEVICES, BY REGION, 2021–2023
  • 5.14 KEY CONFERENCES & EVENTS, 2025–2026
  • 5.15 ADJACENT MARKET ANALYSIS
    VASCULAR CLOSURE DEVICES MARKET
  • 5.16 UNMET NEEDS/END-USER EXPECTATIONS
  • 5.17 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
  • 5.18 INVESTMENT & FUNDING SCENARIO
  • 5.19 IMPACT OF AI/GEN AI ON VASCULAR ACCESS DEVICES MARKET
VASCULAR ACCESS DEVICES MARKET, BY TYPE
104
  • 6.1 INTRODUCTION
  • 6.2 CENTRAL VENOUS ACCESS DEVICES
    PERIPHERALLY INSERTED CENTRAL CATHETERS
    - Better durability and increased clinical utility for extended treatment plans to drive segment
    TUNNELED CATHETERS
    - Lower risk of infection and superior longevity to support segment growth
    NON-TUNNELED CATHETERS
    - Non-tunneled catheters to be used in critical cases with limited peripheral access
    IMPLANTABLE PORTS
    - Implantable conventional ports
    - Implantable power injectable ports
  • 6.3 PERIPHERAL VASCULAR ACCESS DEVICES
    PERIPHERAL VENOUS ACCESS DEVICES
    - Peripheral intravenous catheters
    - Midline catheters
    - Butterfly/Winged steel needles
    PERIPHERAL ARTERIAL ACCESS DEVICES
    - Critical role in continuous hemodynamic monitoring and blood sampling in acute care settings to propel segment growth
  • 6.4 ACCESSORIES
    NEED FOR ENHANCED FUNCTIONALITY, PATIENT SAFETY, AND PROCEDURAL EFFICIENCY TO DRIVE MARKET
  • 6.5 INTRAOSSEOUS VASCULAR ACCESS DEVICES
    CRITICAL ROLE IN EMERGENCY SITUATIONS TO FUEL UPTAKE IN HIGH-STRESS HEALTHCARE FACILITIES
VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION
140
  • 7.1 INTRODUCTION
  • 7.2 INTRAVENOUS ROUTE OF INSERTION
    RISING NEED FOR ADMINISTERING ESSENTIAL TREATMENTS DURING ACUTE CARE TO AID MARKET GROWTH
  • 7.3 SUBCUTANEOUS ROUTE OF INSERTION
    REDUCED INFECTION RISK, BETTER PATIENT COMFORT, AND MINIMAL MAINTENANCE TO AUGMENT MARKET GROWTH
  • 7.4 INTRAOSSEOUS ROUTE OF INSERTION
    NEED FOR RAPID AND RELIABLE ACCESS IN CRITICAL EMERGENCIES TO FUEL UPTAKE
VASCULAR ACCESS DEVICES MARKET, BY APPLICATION
148
  • 8.1 INTRODUCTION
  • 8.2 DRUG ADMINISTRATION
    CHEMOTHERAPY
    - Increased incidence of cancer and advancements in oncology care to drive segment
    OTHER DRUG ADMINISTRATION
  • 8.3 FLUID & NUTRITION ADMINISTRATION
    INCREASING NEED FOR INTRAVENOUS THERAPY IN CHRONIC DISEASES TO SPUR MARKET GROWTH
  • 8.4 BLOOD TRANSFUSION
    FREQUENT NEED FOR BLOOD TRANSFUSION FOR THALASSEMIA AND LYMPHOMA TO BOOST MARKET GROWTH
  • 8.5 DIAGNOSTICS & TESTING
    INCREASING RELIANCE ON ACCURATE DIAGNOSTIC IMAGING, FLUID TESTING, AND PATIENT MONITORING TO AID MARKET GROWTH
VASCULAR ACCESS DEVICES MARKET, BY END USER
163
  • 9.1 INTRODUCTION
  • 9.2 HOSPITALS
    PUBLIC HOSPITALS
    - Increasing demand for affordable healthcare services in emerging economies to drive segment
    PRIVATE HOSPITALS
    - Rising demand for advanced healthcare services and high-quality treatment options to drive market
  • 9.3 CLINICS & AMBULATORY CARE CENTERS
    INCREASING DEMAND FOR OUTPATIENT PROCEDURES AND COST-EFFECTIVE TREATMENTS TO BOOST SEGMENT GROWTH
  • 9.4 OTHER END USERS
VASCULAR ACCESS DEVICES MARKET, BY REGION
174
  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    US
    - US to dominate North American vascular access devices market during forecast period
    CANADA
    - Rising cancer prevalence and advanced research initiatives to propel market growth
  • 10.3 EUROPE
    MACROECONOMIC OUTLOOK FOR EUROPE
    GERMANY
    - Rising obesity rates and growing geriatric population to augment market growth
    UK
    - Increased disease burden to fuel uptake for advanced vascular access devices for better treatment procedures
    FRANCE
    - Presence of vascular access device manufacturers and technological advancements to fuel market growth
    ITALY
    - Strong government healthcare policies to boost market growth
    SPAIN
    - Growing geriatric population and rising incidence of chronic diseases to fuel market growth
    REST OF EUROPE
  • 10.4 ASIA PACIFIC
    MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    CHINA
    - Advanced healthcare infrastructure and high geriatric population to support market growth
    INDIA
    - Rising governmental health expenditure and increasing incidence of chronic diseases to fuel market growth
    JAPAN
    - Increased geriatric population and high prevalence of cancer to drive market
    AUSTRALIA
    - Increased demand for hemodialysis and advancements in healthcare infrastructure to propel market growth
    SOUTH KOREA
    - Rising burden of chronic diseases and increasing aged population to boost market growth
    REST OF ASIA PACIFIC
  • 10.5 LATIN AMERICA
    MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    BRAZIL
    - Growing cancer burden and rising need for long-term treatment for chronic patients to drive market
    MEXICO
    - Increasing focus on dialysis for patients with chronic kidney diseases to drive adoption of advanced vascular access devices
    REST OF LATIN AMERICA
  • 10.6 MIDDLE EAST & AFRICA
    MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
    GCC COUNTRIES
    - Increasing healthcare investments and rising prevalence of chronic diseases to propel market growth
    REST OF MIDDLE EAST & AFRICA
COMPETITIVE LANDSCAPE
357
  • 11.1 INTRODUCTION
  • 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN VASCULAR ACCESS DEVICES MARKET
  • 11.3 REVENUE ANALYSIS, 2019–2023
  • 11.4 MARKET SHARE ANALYSIS, 2023
  • 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS, 2023
    - Company footprint
    - Region footprint
    - Type footprint
    - Route of insertion footprint
    - Application footprint
    - End-user footprint
  • 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
    - Detailed list of key startup/SME players
    - Competitive benchmarking of key emerging players/startups
  • 11.7 COMPANY VALUATION & FINANCIAL METRICS
    FINANCIAL METRICS
    COMPANY VALUATION
  • 11.8 BRAND/PRODUCT COMPARISON
  • 11.9 COMPETITIVE SCENARIO
    PRODUCT LAUNCHES & APPROVALS
    DEALS
    OTHER DEVELOPMENTS
COMPANY PROFILES
378
  • 12.1 KEY PLAYERS
    BECTON, DICKINSON AND COMPANY
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    TELEFLEX INCORPORATED
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    ICU MEDICAL
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    NIPRO
    - Business overview
    - Products offered
    - MnM view
    ANGIODYNAMICS, INC.
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    VYGON
    - Business overview
    - Products offered
    TERUMO CORPORATION
    - Business overview
    - Products offered
    MEDTRONIC PLC
    - Business overview
    - Products offered
    COOK
    - Business overview
    - Products offered
    B. BRAUN SE
    - Business overview
    - Products offered
    - Recent developments
    MERIT MEDICAL SYSTEMS, INC.
    - Business overview
    - Products offered
    - Recent developments
    AMECATH
    - Business overview
    - Products offered
    MEDICAL COMPONENTS, INC.
    - Business overview
    - Products offered
    HEALTHLINE MEDICAL PRODUCTS
    - Business overview
    - Products offered
    ACCESS VASCULAR, INC.
    - Business overview
    - Products offered
  • 12.2 OTHER PLAYERS
    ARGON MEDICAL DEVICES
    PAKUMEDMEDICAL PRODUCTS GMBH
    GUANGDONG BAIHE MEDICAL TECHNOLOGY CO., LTD.
    PFM MEDICAL GMBH
    MEDI-TECH DEVICES PVT. LTD.
    KIMAL
    POLYMEDICURE
    DELTAMED
    NEWTECH MEDICAL DEVICES PVT. LTD.
    SHANGHAI PUYI MEDICAL INSTRUMENTS CO., LTD.
APPENDIX
449
  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 VASCULAR ACCESS DEVICES MARKET: INCLUSIONS & EXCLUSIONS
  • TABLE 2 STANDARD CURRENCY CONVERSION RATES
  • TABLE 3 VASCULAR ACCESS DEVICES MARKET: STUDY ASSUMPTIONS
  • TABLE 4 VASCULAR ACCESS DEVICES MARKET: RISK ANALYSIS
  • TABLE 5 VASCULAR ACCESS DEVICES MARKET: ROLE IN ECOSYSTEM
  • TABLE 6 IMPORT DATA FOR HS CODE 901839, BY COUNTRY, 2018–2023 (USD MILLION)
  • TABLE 7 EXPORT DATA FOR HS CODE 901839, BY COUNTRY, 2018–2023 (USD MILLION)
  • TABLE 8 VASCULAR ACCESS DEVICES MARKET: PORTER’S FIVE FORCES
  • TABLE 9 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS
  • TABLE 10 KEY BUYING CRITERIA FOR VASCULAR ACCESS DEVICES
  • TABLE 11 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 12 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 13 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 14 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 15 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 16 INDICATIVE PRICING TREND OF VASCULAR ACCESS DEVICES, BY KEY PLAYER, 2021–2023
  • TABLE 17 INDICATIVE PRICING TREND OF VASCULAR ACCESS DEVICES, BY REGION, 2021–2023
  • TABLE 18 VASCULAR ACCESS DEVICES MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025–DECEMBER 2026
  • TABLE 19 VASCULAR ACCESS DEVICES MARKET: UNMET NEEDS/END-USER EXPECTATIONS
  • TABLE 20 VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 21 VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 22 CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 23 CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 24 CENTRAL VENOUS ACCESS DEVICES MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 25 CENTRAL VENOUS ACCESS DEVICES MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
  • TABLE 26 PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 27 PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
  • TABLE 28 TUNNELED CATHETERS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 29 TUNNELED CATHETERS MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
  • TABLE 30 NON-TUNNELED CATHETERS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 31 NON-TUNNELED CATHETERS MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
  • TABLE 32 IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 33 IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 34 IMPLANTABLE PORTS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 35 IMPLANTABLE PORTS MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
  • TABLE 36 IMPLANTABLE CONVENTIONAL PORTS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 37 IMPLANTABLE CONVENTIONAL PORTS MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
  • TABLE 38 IMPLANTABLE POWER INJECTABLE PORTS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 39 IMPLANTABLE POWER INJECTABLE PORTS MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
  • TABLE 40 PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 41 PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 42 PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 43 PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
  • TABLE 44 PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 45 PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 46 PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 47 PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
  • TABLE 48 PERIPHERAL INTRAVENOUS CATHETERS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 49 PERIPHERAL INTRAVENOUS CATHETERS MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
  • TABLE 50 MIDLINE CATHETERS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 51 MIDLINE CATHETERS MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
  • TABLE 52 BUTTERFLY/WINGED STEEL NEEDLES MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 53 BUTTERFLY/WINGED STEEL NEEDLES MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
  • TABLE 54 PERIPHERAL ARTERIAL ACCESS DEVICES MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 55 PERIPHERAL ARTERIAL ACCESS DEVICES MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
  • TABLE 56 ACCESSORIES MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 57 ACCESSORIES MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
  • TABLE 58 INTRAOSSEOUS VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 59 INTRAOSSEOUS VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
  • TABLE 60 VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
  • TABLE 61 VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
  • TABLE 62 VASCULAR ACCESS DEVICES MARKET FOR INTRAVENOUS ROUTE OF INSERTION, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 63 VASCULAR ACCESS DEVICES MARKET FOR INTRAVENOUS ROUTE OF INSERTION, BY COUNTRY, 2024–2030 (USD MILLION)
  • TABLE 64 VASCULAR ACCESS DEVICES MARKET FOR SUBCUTANEOUS ROUTE OF INSERTION, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 65 VASCULAR ACCESS DEVICES MARKET FOR SUBCUTANEOUS ROUTE OF INSERTION, BY COUNTRY, 2024–2030 (USD MILLION)
  • TABLE 66 VASCULAR ACCESS DEVICES MARKET FOR INTRAOSSEOUS ROUTE OF INSERTION, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 67 VASCULAR ACCESS DEVICES MARKET FOR INTRAOSSEOUS ROUTE OF INSERTION, BY COUNTRY, 2024–2030 (USD MILLION)
  • TABLE 68 VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 69 VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 70 VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 71 VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 72 VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 73 VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY COUNTRY, 2024–2030 (USD MILLION)
  • TABLE 74 VASCULAR ACCESS DEVICES MARKET FOR CHEMOTHERAPY, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 75 VASCULAR ACCESS DEVICES MARKET FOR CHEMOTHERAPY, BY COUNTRY, 2024–2030 (USD MILLION)
  • TABLE 76 VASCULAR ACCESS DEVICES MARKET FOR OTHER DRUG ADMINISTRATION, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 77 VASCULAR ACCESS DEVICES MARKET FOR OTHER DRUG ADMINISTRATION, BY COUNTRY, 2024–2030 (USD MILLION)
  • TABLE 78 VASCULAR ACCESS DEVICES MARKET FOR FLUID & NUTRITION ADMINISTRATION, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 79 VASCULAR ACCESS DEVICES MARKET FOR FLUID & NUTRITION ADMINISTRATION, BY COUNTRY, 2024–2030 (USD MILLION)
  • TABLE 80 VASCULAR ACCESS DEVICES MARKET FOR BLOOD TRANSFUSION, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 81 VASCULAR ACCESS DEVICES MARKET FOR BLOOD TRANSFUSION, BY COUNTRY, 2024–2030 (USD MILLION)
  • TABLE 82 VASCULAR ACCESS DEVICES MARKET FOR DIAGNOSTICS & TESTING, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 83 VASCULAR ACCESS DEVICES MARKET FOR DIAGNOSTICS & TESTING, BY COUNTRY, 2024–2030 (USD MILLION)
  • TABLE 84 VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 85 VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
  • TABLE 86 VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 87 VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 88 PUBLIC HOSPITALS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 89 PUBLIC HOSPITALS MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
  • TABLE 90 PRIVATE HOSPITALS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 91 PRIVATE HOSPITALS MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
  • TABLE 92 VASCULAR ACCESS DEVICES MARKET FOR CLINICS & AMBULATORY CARE CENTERS, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 93 VASCULAR ACCESS DEVICES MARKET FOR CLINICS & AMBULATORY CARE CENTERS, BY COUNTRY, 2024–2030 (USD MILLION)
  • TABLE 94 VASCULAR ACCESS DEVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 95 VASCULAR ACCESS DEVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2030 (USD MILLION)
  • TABLE 96 VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 97 VASCULAR ACCESS DEVICES MARKET, BY COUNTRY 2024–2030 (USD MILLION)
  • TABLE 98 VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2030 (THOUSAND UNITS)
  • TABLE 99 NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 100 NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
  • TABLE 101 NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 102 NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 103 NORTH AMERICA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 104 NORTH AMERICA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 105 NORTH AMERICA: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 106 NORTH AMERICA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 107 NORTH AMERICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 108 NORTH AMERICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 109 NORTH AMERICA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 110 NORTH AMERICA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 111 NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
  • TABLE 112 NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
  • TABLE 113 NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 114 NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 115 NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 116 NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 117 NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 118 NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
  • TABLE 119 NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 120 NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 121 US: KEY MACROINDICATORS
  • TABLE 122 US: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 123 US: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 124 US: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 125 US: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 126 US: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 127 US: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 128 US: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 129 US: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 130 US: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 131 US: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 132 US: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
  • TABLE 133 US: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
  • TABLE 134 US: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 135 US: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 136 US: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 137 US: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 138 US: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 139 US: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
  • TABLE 140 US: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 141 US: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 142 CANADA: INDICATIVE LIST OF CLINICAL TRIALS CONDUCTED, 2022–2024
  • TABLE 143 CANADA: KEY MACROINDICATORS
  • TABLE 144 CANADA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 145 CANADA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 146 CANADA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 147 CANADA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 148 CANADA: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 149 CANADA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 150 CANADA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 151 CANADA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 152 CANADA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 153 CANADA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 154 CANADA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
  • TABLE 155 CANADA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
  • TABLE 156 CANADA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 157 CANADA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 158 CANADA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 159 CANADA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 160 CANADA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 161 CANADA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
  • TABLE 162 CANADA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 163 CANADA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 164 EUROPE: VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 165 EUROPE: VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
  • TABLE 166 EUROPE: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 167 EUROPE: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 168 EUROPE: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 169 EUROPE: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 170 EUROPE: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 171 EUROPE: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 172 EUROPE: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 173 EUROPE: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 174 EUROPE: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 175 EUROPE: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 176 EUROPE: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
  • TABLE 177 EUROPE: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
  • TABLE 178 EUROPE: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 179 EUROPE: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 180 EUROPE: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 181 EUROPE: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 182 EUROPE: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 183 EUROPE: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
  • TABLE 184 EUROPE: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 185 EUROPE: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 186 GERMANY: KEY MACROINDICATORS
  • TABLE 187 GERMANY: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 188 GERMANY: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 189 GERMANY: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 190 GERMANY: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 191 GERMANY: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 192 GERMANY: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 193 GERMANY: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 194 GERMANY: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 195 GERMANY: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 196 GERMANY: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 197 GERMANY: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
  • TABLE 198 GERMANY: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
  • TABLE 199 GERMANY: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 200 GERMANY: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 201 GERMANY: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 202 GERMANY: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 203 GERMANY: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 204 GERMANY: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
  • TABLE 205 GERMANY: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 206 GERMANY: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 207 UK: KEY MACROINDICATORS
  • TABLE 208 UK: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 209 UK: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 210 UK: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 211 UK: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 212 UK: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 213 UK: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 214 UK: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 215 UK: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 216 UK: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 217 UK: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 218 UK: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
  • TABLE 219 UK: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
  • TABLE 220 UK: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 221 UK: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 222 UK: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 223 UK: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 224 UK: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 225 UK: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
  • TABLE 226 UK: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 227 UK: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 228 FRANCE: KEY MACROINDICATORS
  • TABLE 229 FRANCE: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 230 FRANCE: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 231 FRANCE: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 232 FRANCE: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 233 FRANCE: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 234 FRANCE: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 235 FRANCE: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 236 FRANCE: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 237 FRANCE: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 238 FRANCE: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 239 FRANCE: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
  • TABLE 240 FRANCE: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
  • TABLE 241 FRANCE: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 242 FRANCE: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 243 FRANCE: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 244 FRANCE: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 245 FRANCE: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 246 FRANCE: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
  • TABLE 247 FRANCE: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 248 FRANCE: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 249 ITALY: KEY MACROINDICATORS
  • TABLE 250 ITALY: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 251 ITALY: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 252 ITALY: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 253 ITALY: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 254 ITALY: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 255 ITALY: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 256 ITALY: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 257 ITALY: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 258 ITALY: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 259 ITALY: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 260 ITALY: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
  • TABLE 261 ITALY: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
  • TABLE 262 ITALY: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 263 ITALY: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 264 ITALY: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 265 ITALY: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 266 ITALY: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 267 ITALY: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
  • TABLE 268 ITALY: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 269 ITALY: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 270 SPAIN: KEY MACROINDICATORS
  • TABLE 271 SPAIN: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 272 SPAIN: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 273 SPAIN: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 274 SPAIN: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 275 SPAIN: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 276 SPAIN: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 277 SPAIN: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 278 SPAIN: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 279 SPAIN: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 280 SPAIN: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 281 SPAIN: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
  • TABLE 282 SPAIN: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
  • TABLE 283 SPAIN: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 284 SPAIN: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 285 SPAIN: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 286 SPAIN: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 287 SPAIN: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 288 SPAIN: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
  • TABLE 289 SPAIN: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 290 SPAIN: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 291 REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 292 REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 293 REST OF EUROPE: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 294 REST OF EUROPE: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 295 REST OF EUROPE: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 296 REST OF EUROPE: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 297 REST OF EUROPE: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 298 REST OF EUROPE: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 299 REST OF EUROPE: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 300 REST OF EUROPE: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 301 REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
  • TABLE 302 REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
  • TABLE 303 REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 304 REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 305 REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 306 REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 307 REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 308 REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
  • TABLE 309 REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 310 REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 311 ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 312 ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
  • TABLE 313 ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 314 ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 315 ASIA PACIFIC: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 316 ASIA PACIFIC: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 317 ASIA PACIFIC: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 318 ASIA PACIFIC: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 319 ASIA PACIFIC: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 320 ASIA PACIFIC: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 321 ASIA PACIFIC: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 322 ASIA PACIFIC: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 323 ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
  • TABLE 324 ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
  • TABLE 325 ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 326 ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 327 ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 328 ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 329 ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 330 ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
  • TABLE 331 ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 332 ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 333 CHINA: KEY MACROINDICATORS
  • TABLE 334 CHINA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 335 CHINA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 336 CHINA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 337 CHINA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 338 CHINA: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 339 CHINA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 340 CHINA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 341 CHINA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 342 CHINA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 343 CHINA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 344 CHINA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
  • TABLE 345 CHINA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
  • TABLE 346 CHINA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 347 CHINA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 348 CHINA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 349 CHINA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 350 CHINA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 351 CHINA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
  • TABLE 352 CHINA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 353 CHINA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 354 INDIA: KEY MACROINDICATORS
  • TABLE 355 INDIA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 356 INDIA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 357 INDIA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 358 INDIA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 359 INDIA: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 360 INDIA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 361 INDIA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 362 INDIA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 363 INDIA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 364 INDIA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 365 INDIA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
  • TABLE 366 INDIA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
  • TABLE 367 INDIA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 368 INDIA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 369 INDIA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 370 INDIA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 371 INDIA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 372 INDIA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
  • TABLE 373 INDIA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 374 INDIA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 375 JAPAN: KEY MACROINDICATORS
  • TABLE 376 JAPAN: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 377 JAPAN: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 378 JAPAN: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 379 JAPAN: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 380 JAPAN: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 381 JAPAN: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 382 JAPAN: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 383 JAPAN: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 384 JAPAN: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 385 JAPAN: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 386 JAPAN: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
  • TABLE 387 JAPAN: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
  • TABLE 388 JAPAN: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 389 JAPAN: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 390 JAPAN: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 391 JAPAN: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 392 JAPAN: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 393 JAPAN: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
  • TABLE 394 JAPAN: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 395 JAPAN: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 396 AUSTRALIA: KEY MACROINDICATORS
  • TABLE 397 AUSTRALIA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 398 AUSTRALIA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 399 AUSTRALIA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 400 AUSTRALIA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 401 AUSTRALIA: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 402 AUSTRALIA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 403 AUSTRALIA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 404 AUSTRALIA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 405 AUSTRALIA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 406 AUSTRALIA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 407 AUSTRALIA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
  • TABLE 408 AUSTRALIA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
  • TABLE 409 AUSTRALIA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 410 AUSTRALIA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 411 AUSTRALIA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 412 AUSTRALIA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 413 AUSTRALIA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 414 AUSTRALIA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
  • TABLE 415 AUSTRALIA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 416 AUSTRALIA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 417 SOUTH KOREA: KEY MACROINDICATORS
  • TABLE 418 SOUTH KOREA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 419 SOUTH KOREA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 420 SOUTH KOREA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 421 SOUTH KOREA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 422 SOUTH KOREA: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 423 SOUTH KOREA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 424 SOUTH KOREA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 425 SOUTH KOREA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 426 SOUTH KOREA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 427 SOUTH KOREA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 428 SOUTH KOREA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
  • TABLE 429 SOUTH KOREA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
  • TABLE 430 SOUTH KOREA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 431 SOUTH KOREA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 432 SOUTH KOREA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 433 SOUTH KOREA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 434 SOUTH KOREA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 435 SOUTH KOREA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
  • TABLE 436 SOUTH KOREA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 437 SOUTH KOREA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 438 REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 439 REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 440 REST OF ASIA PACIFIC: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 441 REST OF ASIA PACIFIC: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 442 REST OF ASIA PACIFIC: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 443 REST OF ASIA PACIFIC: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 444 REST OF ASIA PACIFIC: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 445 REST OF ASIA PACIFIC: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 446 REST OF ASIA PACIFIC: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 447 REST OF ASIA PACIFIC: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 448 REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
  • TABLE 449 REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
  • TABLE 450 REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 451 REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 452 REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 453 REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 454 REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 455 REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
  • TABLE 456 REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 457 REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 458 LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 459 LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
  • TABLE 460 LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 461 LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 462 LATIN AMERICA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 463 LATIN AMERICA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 464 LATIN AMERICA: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 465 LATIN AMERICA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 466 LATIN AMERICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 467 LATIN AMERICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 468 LATIN AMERICA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 469 LATIN AMERICA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 470 LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
  • TABLE 471 LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
  • TABLE 472 LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 473 LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 474 LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 475 LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 476 LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 477 LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
  • TABLE 478 LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 479 LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 480 BRAZIL: KEY MACROINDICATORS
  • TABLE 481 BRAZIL: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 482 BRAZIL: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 483 BRAZIL: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 484 BRAZIL: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 485 BRAZIL: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 486 BRAZIL: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 487 BRAZIL: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 488 BRAZIL: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 489 BRAZIL: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 490 BRAZIL: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 491 BRAZIL: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
  • TABLE 492 BRAZIL: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
  • TABLE 493 BRAZIL: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 494 BRAZIL: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 495 BRAZIL: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 496 BRAZIL: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 497 BRAZIL: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 498 BRAZIL: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
  • TABLE 499 BRAZIL: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 500 BRAZIL: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 501 MEXICO: KEY MACROINDICATORS
  • TABLE 502 MEXICO: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 503 MEXICO: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 504 MEXICO: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 505 MEXICO: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 506 MEXICO: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 507 MEXICO: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 508 MEXICO: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 509 MEXICO: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 510 MEXICO: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 511 MEXICO: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 512 MEXICO: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
  • TABLE 513 MEXICO: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
  • TABLE 514 MEXICO: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 515 MEXICO: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 516 MEXICO: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 517 MEXICO: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 518 MEXICO: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 519 MEXICO: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
  • TABLE 520 MEXICO: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 521 MEXICO: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 522 REST OF LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 523 REST OF LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 524 REST OF LATIN AMERICA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 525 REST OF LATIN AMERICA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 526 REST OF LATIN AMERICA: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 527 REST OF LATIN AMERICA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 528 REST OF LATIN AMERICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 529 REST OF LATIN AMERICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 530 REST OF LATIN AMERICA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 531 REST OF LATIN AMERICA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 532 REST OF LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
  • TABLE 533 REST OF LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
  • TABLE 534 REST OF LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 535 REST OF LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 536 REST OF LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 537 REST OF LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 538 REST OF LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 539 REST OF LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
  • TABLE 540 REST OF LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 541 REST OF LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 542 MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY REGION, 2021–2023 (USD MILLION)
  • TABLE 543 MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY REGION, 2024–2030 (USD MILLION)
  • TABLE 544 MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 545 MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 546 MIDDLE EAST & AFRICA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 547 MIDDLE EAST & AFRICA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 548 MIDDLE EAST & AFRICA: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 549 MIDDLE EAST & AFRICA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 550 MIDDLE EAST & AFRICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 551 MIDDLE EAST & AFRICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 552 MIDDLE EAST & AFRICA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 553 MIDDLE EAST & AFRICA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 554 MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
  • TABLE 555 MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
  • TABLE 556 MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 557 MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 558 MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 559 MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 560 MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 561 MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
  • TABLE 562 MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 563 MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 564 GCC COUNTRIES: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 565 GCC COUNTRIES: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 566 GCC COUNTRIES: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 567 GCC COUNTRIES: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 568 GCC COUNTRIES: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 569 GCC COUNTRIES: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 570 GCC COUNTRIES: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 571 GCC COUNTRIES: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 572 GCC COUNTRIES: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 573 GCC COUNTRIES: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 574 GCC COUNTRIES: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
  • TABLE 575 GCC COUNTRIES: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
  • TABLE 576 GCC COUNTRIES: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 577 GCC COUNTRIES: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 578 GCC COUNTRIES: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 579 GCC COUNTRIES: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 580 GCC COUNTRIES: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 581 GCC COUNTRIES: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
  • TABLE 582 GCC COUNTRIES: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 583 GCC COUNTRIES: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 584 REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 585 REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 586 REST OF MIDDLE EAST & AFRICA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 587 REST OF MIDDLE EAST & AFRICA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 588 REST OF MIDDLE EAST & AFRICA: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 589 REST OF MIDDLE EAST & AFRICA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 590 REST OF MIDDLE EAST & AFRICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 591 REST OF MIDDLE EAST & AFRICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 592 REST OF MIDDLE EAST & AFRICA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 593 REST OF MIDDLE EAST & AFRICA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 594 REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)
  • TABLE 595 REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)
  • TABLE 596 REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 597 REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 598 REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 599 REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 600 REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 601 REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
  • TABLE 602 REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 603 REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 604 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN VASCULAR ACCESS DEVICES MARKET
  • TABLE 605 VASCULAR ACCESS DEVICES MARKET: DEGREE OF COMPETITION
  • TABLE 606 VASCULAR ACCESS DEVICES MARKET: REGION FOOTPRINT
  • TABLE 607 VASCULAR ACCESS DEVICES MARKET: TYPE FOOTPRINT
  • TABLE 608 VASCULAR ACCESS DEVICES MARKET: ROUTE OF INSERTION FOOTPRINT
  • TABLE 609 VASCULAR ACCESS DEVICES MARKET: APPLICATION FOOTPRINT
  • TABLE 610 VASCULAR ACCESS DEVICES MARKET: END-USER FOOTPRINT
  • TABLE 611 VASCULAR ACCESS DEVICES MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
  • TABLE 612 VASCULAR ACCESS DEVICES MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
  • TABLE 613 VASCULAR ACCESS DEVICES MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JANUARY 2025
  • TABLE 614 VASCULAR ACCESS DEVICES MARKET: DEALS, JANUARY 2021–JANUARY 2025
  • TABLE 615 VASCULAR ACCESS DEVICES MARKET: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025
  • TABLE 616 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
  • TABLE 617 BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED
  • TABLE 618 BECTON, DICKINSON AND COMPANY: DEALS, JANUARY 2021–JANUARY 2025
  • TABLE 619 TELEFLEX INCORPORATED: COMPANY OVERVIEW
  • TABLE 620 TELEFLEX INCORPORATED: PRODUCTS OFFERED
  • TABLE 621 TELEFLEX INCORPORATED: PRODUCT LAUNCHES, JANUARY 2021–JANUARY 2025
  • TABLE 622 TELEFLEX INCORPORATED: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025
  • TABLE 623 ICU MEDICAL: COMPANY OVERVIEW
  • TABLE 624 ICU MEDICAL: PRODUCTS OFFERED
  • TABLE 625 ICU MEDICAL: DEALS, JANUARY 2021–JANUARY 2025
  • TABLE 626 NIPRO: COMPANY OVERVIEW
  • TABLE 627 NIPRO: PRODUCTS OFFERED
  • TABLE 628 ANGIODYNAMICS, INC.: COMPANY OVERVIEW
  • TABLE 629 ANGIODYNAMICS, INC.: PRODUCTS OFFERED
  • TABLE 630 ANGIODYNAMICS, INC.: PRODUCT APPROVALS, JANUARY 2021–JANUARY 2025
  • TABLE 631 ANGIODYNAMICS, INC.: DEALS, JANUARY 2021–JANUARY 2025
  • TABLE 632 VYGON: COMPANY OVERVIEW
  • TABLE 633 VYGON: PRODUCTS OFFERED
  • TABLE 634 TERUMO CORPORATION: COMPANY OVERVIEW
  • TABLE 635 TERUMO CORPORATION: PRODUCTS OFFERED
  • TABLE 636 MEDTRONIC PLC: COMPANY OVERVIEW
  • TABLE 637 MEDTRONIC PLC: PRODUCTS OFFERED
  • TABLE 638 COOK: COMPANY OVERVIEW
  • TABLE 639 COOK: PRODUCTS OFFERED
  • TABLE 640 B. BRAUN SE: COMPANY OVERVIEW
  • TABLE 641 B. BRAUN SE: PRODUCTS OFFERED
  • TABLE 642 B. BRAUN SE: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JANUARY 2025
  • TABLE 643 B. BRAUN SE: DEALS, JANUARY 2021–JANUARY 2025
  • TABLE 644 MERIT MEDICAL SYSTEMS, INC.: COMPANY OVERVIEW
  • TABLE 645 MERIT MEDICAL SYSTEMS, INC.: PRODUCTS OFFERED
  • TABLE 646 MERIT MEDICAL SYSTEMS, INC.: DEALS, JANUARY 2021–JANUARY 2025
  • TABLE 647 AMECATH: COMPANY OVERVIEW
  • TABLE 648 AMECATH: PRODUCTS OFFERED
  • TABLE 649 MEDICAL COMPONENTS, INC.: COMPANY OVERVIEW
  • TABLE 650 MEDICAL COMPONENTS, INC.: PRODUCTS OFFERED
  • TABLE 651 HEALTHLINE MEDICAL PRODUCTS: COMPANY OVERVIEW
  • TABLE 652 HEALTHLINE MEDICAL PRODUCTS: PRODUCTS OFFERED
  • TABLE 653 ACCESS VASCULAR, INC.: COMPANY OVERVIEW
  • TABLE 654 ACCESS VASCULAR, INC.: PRODUCTS OFFERED
  • TABLE 655 ARGON MEDICAL DEVICES: COMPANY OVERVIEW
  • TABLE 656 PAKUMEDMEDICAL PRODUCTS GMBH: COMPANY OVERVIEW
  • TABLE 657 GUANGDONG BAIHE MEDICAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW
  • TABLE 658 PFM MEDICAL GMBH: COMPANY OVERVIEW
  • TABLE 659 MEDI-TECH DEVICES PVT. LTD.: COMPANY OVERVIEW
  • TABLE 660 KIMAL: COMPANY OVERVIEW
  • TABLE 661 POLYMEDICURE: COMPANY OVERVIEW
  • TABLE 662 DELTAMED: COMPANY OVERVIEW
  • TABLE 663 NEWTECH MEDICAL DEVICES PVT. LTD.: COMPANY OVERVIEW
  • TABLE 664 SHANGHAI PUYI MEDICAL INSTRUMENTS CO., LTD.: COMPANY OVERVIEW
LIST OF FIGURES
 
  • FIGURE 1 VASCULAR ACCESS DEVICES MARKET: SEGMENTS CONSIDERED & GEOGRAPHICAL SPREAD
  • FIGURE 2 VASCULAR ACCESS DEVICES MARKET: YEARS CONSIDERED
  • FIGURE 3 VASCULAR ACCESS DEVICES MARKET: RESEARCH DESIGN
  • FIGURE 4 VASCULAR ACCESS DEVICES MARKET: KEY DATA FROM SECONDARY SOURCES
  • FIGURE 5 VASCULAR ACCESS DEVICES MARKET: KEY PRIMARY SOURCES
  • FIGURE 6 VASCULAR ACCESS DEVICES MARKET: KEY DATA FROM PRIMARY SOURCES
  • FIGURE 7 VASCULAR ACCESS DEVICES MARKET: KEY INSIGHTS FROM INDUSTRY EXPERTS
  • FIGURE 8 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 9 MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS
  • FIGURE 10 VASCULAR ACCESS DEVICES MARKET: TOP-DOWN APPROACH
  • FIGURE 11 MARKET SIZE ESTIMATION: DEMAND-SIDE ANALYSIS
  • FIGURE 12 IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN VASCULAR ACCESS DEVICES MARKET
  • FIGURE 13 VASCULAR ACCESS DEVICES MARKET: CAGR PROJECTIONS
  • FIGURE 14 VASCULAR ACCESS DEVICES MARKET: DATA TRIANGULATION
  • FIGURE 15 CENTRAL VENOUS ACCESS DEVICES TO ACCOUNT FOR LARGEST MARKET SHARE DURING STUDY PERIOD
  • FIGURE 16 TUNNELED CATHETERS TO GROW AT HIGHEST CAGR IN CENTRAL VENOUS ACCESS DEVICES MARKET FROM 2024 TO 2030
  • FIGURE 17 IMPLANTABLE POWER INJECTABLE PORTS TO REGISTER HIGHEST GROWTH RATE IN IMPLANTABLE PORTS MARKET DURING STUDY PERIOD
  • FIGURE 18 PERIPHERAL VENOUS ACCESS DEVICES SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE DURING FORECAST PERIOD
  • FIGURE 19 PERIPHERAL INTRAVENOUS CATHETERS TO COMMAND LARGEST MARKET SHARE DURING STUDY PERIOD
  • FIGURE 20 INTRAVENOUS ROUTE OF INSERTION TO HOLD LARGEST MARKET SHARE FROM 2024 TO 2030
  • FIGURE 21 DRUG ADMINISTRATION TO COMMAND LARGEST SHARE IN APPLICATIONS SEGMENT
  • FIGURE 22 CHEMOTHERAPY TO BE FASTEST-GROWING SEGMENT DURING FORECAST PERIOD
  • FIGURE 23 HOSPITALS TO ACCOUNT FOR LARGEST MARKET SHARE DURING FORECAST PERIOD
  • FIGURE 24 PUBLIC HOSPITALS TO COMMAND LARGER SHARE OF HOSPITALS MARKET DURING FORECAST PERIOD
  • FIGURE 25 ASIA PACIFIC TO BE FASTEST-GROWING REGIONAL MARKET FOR VASCULAR ACCESS DEVICES
  • FIGURE 26 RISING PREVALENCE OF CHRONIC DISEASES REQUIRING LONG-TERM TREATMENT AND CARE TO DRIVE MARKET
  • FIGURE 27 US AND HOSPITALS SEGMENT COMMANDED LARGEST MARKET SHARE IN 2023
  • FIGURE 28 ASIA PACIFIC COUNTRIES TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 29 ASIA PACIFIC TO COMMAND HIGHEST GROWTH RATE FROM 2024 TO 2030
  • FIGURE 30 EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES DURING STUDY PERIOD
  • FIGURE 31 VASCULAR ACCESS DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 32 VASCULAR ACCESS DEVICES MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 33 VASCULAR ACCESS DEVICES MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 34 VASCULAR ACCESS DEVICES MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 35 VASCULAR ACCESS DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS
  • FIGURE 36 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS
  • FIGURE 37 KEY BUYING CRITERIA FOR TOP THREE PRODUCT TYPES
  • FIGURE 38 NUMBER OF PATENT PUBLICATIONS (JANUARY 2014–DECEMBER 2024)
  • FIGURE 39 TOP APPLICANTS (COMPANIES/INSTITUTIONS) FOR VASCULAR ACCESS DEVICE PATENTS (JANUARY 2014−DECEMBER 2024)
  • FIGURE 40 TOP APPLICANT COUNTRIES/REGIONS FOR VASCULAR ACCESS DEVICES (JANUARY 2014− DECEMBER 2024)
  • FIGURE 41 VASCULAR CLOSURE DEVICES MARKET: MARKET OVERVIEW
  • FIGURE 42 VASCULAR ACCESS DEVICES MARKET: TRENDS AND DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
  • FIGURE 43 VASCULAR ACCESS DEVICES MARKET: FUNDING AND NUMBER OF DEALS, 2019–2023
  • FIGURE 44 VASCULAR ACCESS DEVICES MARKET: IMPACT OF AI/GEN AI
  • FIGURE 45 VASCULAR ACCESS DEVICES MARKET: GEOGRAPHIC SNAPSHOT
  • FIGURE 46 NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET SNAPSHOT
  • FIGURE 47 ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET SNAPSHOT
  • FIGURE 48 REVENUE ANALYSIS OF KEY PLAYERS IN VASCULAR ACCESS DEVICES MARKET (2019–2023)
  • FIGURE 49 MARKET SHARE ANALYSIS OF KEY PLAYERS IN VASCULAR ACCESS DEVICES MARKET (2023)
  • FIGURE 50 VASCULAR ACCESS DEVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 51 VASCULAR ACCESS DEVICES MARKET: COMPANY FOOTPRINT
  • FIGURE 52 VASCULAR ACCESS DEVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 53 EV/EBITDA OF KEY VENDORS
  • FIGURE 54 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 55 VASCULAR ACCESS DEVICES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 56 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
  • FIGURE 57 TELEFLEX INCORPORATED: COMPANY SNAPSHOT
  • FIGURE 58 ICU MEDICAL: COMPANY SNAPSHOT
  • FIGURE 59 NIPRO: COMPANY SNAPSHOT
  • FIGURE 60 ANGIODYNAMICS, INC.: COMPANY SNAPSHOT
  • FIGURE 61 TERUMO CORPORATION: COMPANY SNAPSHOT
  • FIGURE 62 MEDTRONIC PLC: COMPANY SNAPSHOT
  • FIGURE 63 B. BRAUN SE: COMPANY SNAPSHOT
  • FIGURE 64 MERIT MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT

 

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, fundamental market dynamics, and key player strategies.

Secondary Research

The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, investor presentations, SEC filings of companies and publications from government sources [such as National Institutes of Health (NIH), US FDA, US Census Bureau, World Health Organization (WHO), International Trade Administration (ITA), Global Burden of Disease Study, and Centers for Medicare and Medicaid Services (CMS) were referred to identify and collect information for the global vaccine storage equipment market study. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations in the vaccine storage equipment market. The primary sources from the demand side include pharmaceutical companies, vaccination centers, hospitals & Clinics, pharmacies, and research academics and universities. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends & key market dynamics.

A breakdown of the primary respondents is provided below:

Vascular Access Devices Market

*C-level primaries include CEOs, CFOs, COOs, and VPs.

*Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

Note: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = < USD 1.00 billion.

Source: MarketsandMarkets Analysis

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

For the global market value, annual revenues were calculated based on the revenue mapping of major product manufacturers and OEMs active in the global vascular access device equipment market. All the major product manufacturers were identified at the global and/or country/regional level. Revenue mapping for the respective business segments/sub-segments was done for the major players. Also, the global vascular access device market was split into various segments and sub-segments based on:

  • List of major players operating in the products market at the regional and/or country level
  • Product mapping of various vaccine storage equipment manufacturers at the regional and/or country level
  • Mapping of annual revenue generated by listed major players from vascular access device (or the nearest reported business unit/product category)
  • Extrapolation of the revenue mapping of the listed major players to derive the global market value of the respective segments/subsegments
  • Summation of the market value of all segments/subsegments to arrive at the global vascular access device market

The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

Market Size Estimation (Bottom Up approach & Top down approach)

Vascular Access Devices Market

Data Triangulation

After arriving at the overall size of the global vascular access device market through the above-mentioned methodology, this market was split into several segments and subsegments. The data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact market value data for the key segments and subsegments. The extrapolated market data was triangulated by studying various macro indicators and regional trends from both demand- and supply-side participants.

Market Definition

A vascular access device (VAD) is a medical tool inserted into a vein or artery to provide direct access to the bloodstream for diagnostic or therapeutic purposes. It is commonly used for administering medications, fluids, blood products, or nutrients and for drawing blood samples. Vascular access devices are essential for patients requiring long-term intravenous treatments, such as chemotherapy or dialysis. They are classified as central or peripheral devices based on the insertion site and duration of use. These devices are usually inserted in the arm, chest, or leg, and remains in place for an extended period.

Stakeholders

  • Vascular access device manufacturers and distributors
  • Interventional cardiology vascular device manufacturers
  • Healthcare institutions (hospitals, medical schools, group practices, individual surgeons, and governing bodies)
  • Vendors/service providers
  • Research institutes
  • Niche companies manufacturing novel vascular access devices
  • Research & consulting firms

Report Objectives

  • To describe, analyze, and forecast the vascular access device market by product, by type, by route of insertion, by application, by end user, and region
  • To describe and forecast the vascular access device market in key regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa.
  • To provide detailed information regarding the drivers, restraints, opportunities, and challenges influencing the market growth
  • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for market players
  • To profile key players and comprehensively analyze their market shares and core competencies2 in the vascular access device market
  • To analyze competitive developments such as partnerships, collaborations, agreements & acquisitions, product launches, expansions, and R&D activities in the vascular access device market
  • To analyze the impact of AI/Gen AI on the vascular access device market in terms of its capabilities, potential, use cases, and future

Previous Versions of this Report

Vascular Access Device Market by Type (Central (Peripheral, Tunneled, Non- tunneled, Implanted Ports), Peripheral (Short, Midline, Winged)), Application (Drug, Blood, Fluid, Diagnostic), End User (Hospitals, Clinics, Ambulatory) - Global Forecast to 2028

Report Code MD 5434
Published in Jul, 2023, By MarketsandMarkets™

Vascular Access Device Market by Type (Central (Peripheral, Tunneled, Non- tunneled, Implanted Ports), Peripheral (Short, Midline, Winged)), Application (Drug, Blood, Fluid, Diagnostic), End User (Hospitals, Clinics, Ambulatory) - Global Forecast to 2028

Report Code MD 5434
Published in Jul, 2017, By MarketsandMarkets™

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Vascular Access Devices Market

DMCA.com Protection Status